ADAR1 Capital Management »

Arrowhead Pharmaceuticals shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $17k 600 28.60
2023-12-31 $9.2k 300 30.60

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Arrowhead Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Slate Path Capital
T. Rowe Price Investment Management
Geode Capital Management
Siren
Jpmorgan Chase & Co
Morgan Stanley
Northern Trust
Citadel Advisors
Goldman Sachs Group
Charles Schwab Investment Management
Rokos Capital Management

View all funds holding Arrowhead Pharmaceuticals